Breast Cancer Trial, Recruiting NCT07040891 Sponsor: Abramson Cancer Center at Penn Medicine Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07040891
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For oncology team members (doctors, nurses, and coordinators):

  • People who work as part of an oncology team (such as physicians, nurses, nurse practitioners, or trial coordinators) who regularly offer, discuss consent, and enroll patients in breast cancer clinical trials at the Abramson Cancer Center in Philadelphia, PA
  • People who are able to give their informed consent to participate in the study

For patient participants:

  • Adults aged 18 or older
  • People who have been diagnosed with breast cancer and have been identified as potentially eligible for at least one breast cancer treatment clinical trial
  • People who have been seen at the Abramson Cancer Center by an oncology team member who is also participating in this study
  • People who are able to give their informed consent to participate in the study

Who may not be able to join:

For oncology team members:

  • People who have already completed the "Just ASK™" training program

For patient participants:

  • People who have already agreed to take part in a breast cancer clinical trial for their treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Carmen E Guerra, MD, University of Pennsylvania

Phone: 215-349-5374

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Abramson Cancer Center at Penn Medicine
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rates of discussion of breast cancer clinical trials

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov